Risk factors and comparisons of clinical nephrotoxicity of aminoglycosides
- 30 June 1986
- journal article
- clinical trial
- Published by Elsevier in The American Journal of Medicine
- Vol. 80 (6) , 119-125
- https://doi.org/10.1016/0002-9343(86)90489-4
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Renal disposition of gentamicin, dibekacin, tobramycin, netilmicin, and amikacin in humansAntimicrobial Agents and Chemotherapy, 1985
- Ceftazidime and renal functionJournal of Antimicrobial Chemotherapy, 1984
- Calcium is a competitive inhibitor of gentamicin-renal membrane binding interactions and dietary calcium supplementation protects against gentamicin nephrotoxicity.Journal of Clinical Investigation, 1984
- Clinical significance of renal changes engendered by aminoglycosides in manJournal of Antimicrobial Chemotherapy, 1984
- Aminoglycoside Nephrotoxicity in HumansClinical Infectious Diseases, 1983
- Controlled Comparison of Gentamicin and Tobramycin NephrotoxicityAmerican Journal of Nephrology, 1983
- Reduction of experimental gentamicin nephrotoxicity in rats by dietary calcium loadingAntimicrobial Agents and Chemotherapy, 1982
- Prospective comparative study of efficacy and toxicity of netilmicin and amikacinAntimicrobial Agents and Chemotherapy, 1980
- Controlled Comparison of Amikacin and GentamicinNew England Journal of Medicine, 1977
- Gentamicin Blood Levels: a Guide to NephrotoxicityAntimicrobial Agents and Chemotherapy, 1975